Results 151 to 160 of about 268,028 (214)

LGALS3BP antibody-drug conjugate enhances tumor-infiltrating lymphocytes and synergizes with immunotherapy to restrain neuroblastoma growth. [PDF]

J Transl Med
Cela I, Capone E, Pece A, Lovato G, Simeone P, Colasante M, Lamolinara A, Piro A, Iezzi M, Lanuti P, De Laurenzi V, Ippoliti R, Iacobelli S, Sala G.   +13 more
europepmc   +1 more source

TRIM59-mediated ferroptosis enhances neuroblastoma development and chemosensitivity through p53 ubiquitination and degradation

Heliyon
Neuroblastoma, predominantly afflicting young individuals, is characterized as an embryonal tumor, with poor prognosis primarily attributed to chemoresistance.
Yingbei Liu, Na Jiang, Weicheng Chen, Wenbo Zhang, Xiao Shen, Bing Jia, Gang Chen   +6 more
doaj  

Mechanisms and molecular characterization of relapsed/refractory neuroblastomas. [PDF]

Front Oncol
Chen C, Wei Z.
europepmc   +1 more source

Cell death pathway regulation by fatty acid metabolism-related genes in neuroblastoma: a multi-omics analysis identifying CHD5 as a novel biomarker. [PDF]

Discov Oncol
Chen Y, Liu J, Jia Y, Yang J, Jin Y, Liu Y, Zhong B, Zhao Q.   +7 more
europepmc   +1 more source

SAP30, an oncogenic driver of progression, poor survival, and drug resistance in neuroblastoma

Molecular Therapy: Nucleic Acids
Neuroblastoma is the most devastating extracranial solid malignancy in children. Despite an intense treatment regimen, the prognosis for high-risk neuroblastoma patients remains poor, with less than 40% survival.
Philip Prathipati, Anup S. Pathania, Nagendra K. Chaturvedi, Subash C. Gupta, Siddappa N. Byrareddy, Don W. Coulter, Kishore B. Challagundla   +6 more
doaj  

c-Jun promotes neuroblastoma cell differentiation by inhibiting APC formation via CDC16 and reduces neuroblastoma malignancy. [PDF]

Biol Direct
Wang Y, Huang J, Song Z, Zhang S, Guo H, Leng Q, Fang N, Ji S, Yang J.   +8 more
europepmc   +1 more source

Transcriptionally distinct malignant neuroblastoma populations show selective response to adavosertib treatment. [PDF]

Neurotherapeutics
Hsieh CH, Chen YX, Tseng TY, Li A, Huang HC, Juan HF.   +5 more
europepmc   +1 more source

Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries

Nature Genetics, 2017
V. Boeva, Caroline Louis-Brennetot, Agathe Peltier, Simon Durand, Cecile Pierre-Eugene, V. Raynal, H. Etchevers, Sophie Thomas, Alban Lermine, E. Daudigeos-Dubus, B. Geoerger, M. Orth, T. G. Grünewald, Elise Diaz, B. Ducos, D. Surdez, A. Carcaboso, I. Medvedeva, T. Deller, V. Combaret, E. Lapouble, G. Pierron, Sandrine Grossetête-Lalami, S. Baulande, G. Schleiermacher, E. Barillot, H. Rohrer, O. Delattre, I. Janoueix-Lerosey   +28 more
semanticscholar   +1 more source

At the crossroad between Ewing sarcoma and neuroblastoma: a report of two cases of Ewing sarcoma with post treatment neuroblastoma-like differentiation. [PDF]

Diagn Pathol
Arcovito G, Aringhieri G, Zampa V, Coccoli L, Andreani L, Franchi A.   +5 more
europepmc   +1 more source

Emerging clinical and research approaches in targeted therapies for high-risk neuroblastoma. [PDF]

Front Oncol
AlKhazal A, Chohan S, Ross DJ, Kim J, Brown EG.   +4 more
europepmc   +1 more source